> MEDIA   Overview   Press Releases   Media Stories   Download Center   Video Gallery   Photo Gallery   Media Contacts

Press Releases 2017 2018 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005       December 2015 24 Dec  Biocon Introduces CIMIVIR-L™ for  Hepatitis-C in India 09 Dec  NeoBiocon Partners with Novartis to offer  Vildagliptin for Diabetics in UAE   November 2015 13 Nov  Biocon's Nationwide 'Winning with  Diabetes' Campaign Raises Awareness on  Disease Prevention & Management 03 Nov  Biocon is the Only Asian Company to be  ranked in Top 20 Global Biotech Employers  for 2015   October 2015 20 Oct  Biocon Q2FY16 Revenues up 12%; Net  Profit up 200%; Syngene delivers 30%  growth   September 2015 15 Sept  Biocon Inaugurates World Class Devices  Facility & Introduces Basalog One™  Forges Ahead on 'Make in India for the  World' Mission   July 2015 23 Jul  Biocon's Earnings Surge in Q1 FY16;  Revenue up by 15% at Rs. 857 Crore,  Net pofit up by 23% at Rs. 126 Crore   May 2015 07 May  Biocon-Mylan Programs Make Progress:  PEG-G-CSF and Adalimumab enter Phase  3 clinical trials; Patient recruitment for one  Insulin Glargine Phase 3 study completed   April 2015 30 Apr  Biocon top line grows 15% in Q4 FY15;  Research Services delivers 27% growth;  FY15 Revenues at Rs. 3143 Crore, PAT at  Rs. 497 Crore 28 Apr  Biocon's CRO Arm Syngene Seeks  Approval for IPO, Files DRHP; Offer allows  Biocon to monetize its shareholding in  Syngene 09 Apr  Biocon Strengthens its Presence in Mexico;  Receives Approval for Insulin Glargine  through its partner PiSA Farmaceutica 08 Apr  Biocon Foundation Recognized for  Outstanding Contribution to Public Health  by WHO - India   March 2015 05 Mar  Kiran Mazumdar-Shaw Honoured by  Federation University Australia   Jan 2015 22 Jan  Dr Jeremy Levin Joins Biocon's Board of  Directors 22 Jan  Dr Vijay Kuchroo Joins Biocon's Board of  Directors 22 Jan  Biocon Q3 FY15 Revenues at Rs. 779  Crore, PAT at Rs. 91 Crore; Research  Services delivers 20% growth; Board  approves listing Syngene via Offer for Sale

Biocon Businesses Recommended sites Biocon on     Home About Us Investor Relations Media Relations Careers Site Map Contact Us Our Growth Accelerators Fact Sheet Branded Formulations Biopharmaceuticals Research Services Active Discovery Program ABLE Karnataka Vision Group on BT Syngene International Biocon Academy                   Report adverse event/side effects and product complaints               * Disclaimer            © 2018, Biocon. All Rights Reserved